Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Siticolin P
- Development stage
- Unknown
- Lead developer
- Cytech Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Siticolin P is a combination nootropic tablet developed by Cytech Pharma, containing 500 mg of citicoline and 400 mg of piracetam. Citicoline acts as a metabolic precursor for phosphatidylcholine, supporting the synthesis and repair of neuronal membranes and enhancing neurotransmitter production. Piracetam is a cyclic derivative of GABA that exerts various neuromodulatory effects, including the improvement of membrane fluidity and the modulation of neurotransmission. The oral formulation is primarily indicated for the management of cognitive impairment, neurocognitive support, and recovery following an ischemic stroke. As a branded generic product, it leverages the complementary pathways of its components to support brain health through membrane repair and neurotransmitter synthesis modulation.
- Brand names
- Siticolin P
- Other names
- citicoline + piracetam
02
Targets
AMPAR (AMPA receptor)mAChR (Muscarinic acetylcholine receptors)CACNA1B (Voltage-dependent N-type calcium channel subunit alpha-1B)NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on Siticolin P.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Siticolin P.